OneVentures

Venture Capital Est. 2010
Website →
≥AUD 1B
Firm FUM (minimum)
Type
Venture Capital
HQ
Sydney, NSW, Australia
Founded
2010
Focus
Life Sciences · Healthcare & Life Sciences · Technology

About

OneVentures is an Australian investment manager with technology growth-equity and clinical-stage life-sciences investment pillars, alongside a growth-credit practice providing debt facilities to technology companies.

Strategies

Venture Capital
Focused strategy
Venture Debt
Focused strategy
Growth Equity
Focused strategy
Private Credit
Sources

Profile sources

  1. one-ventures.com.au — Life Sciences, Healthcare & Life Sciences
  2. one-ventures.com.au — Healthcare & Life Sciences, Technology

Locations & investment markets

  • Office · Sydney, Australia

  • Headquarters · Sydney, Australia

  • Office · Melbourne, Australia

  • Investment market · Australia

    The homepage states that OneVentures scales Australian technology and healthcare companies, supporting Australia as a stated investment focus without implying exclusivity.

Reported capital

Capital and location details checked 2026-10-14.

Investment Criteria

Investment size
AUD 5M - AUD 20M

Reported investment size. Actual commitments may vary by stage, ownership and follow-on participation.

Investment Stages
Stages
Series A Series B Growth
Investment Geographies
Primary Markets
Australia
Coverage
Country-focused
Regions
Oceania

Coverage is a guide only.

Location

Headquarters
Sydney, NSW, Australia
More investors with offices in Sydney
Office Presence
1 country
Australia
2 known offices
Sydney, NSW, Australia (HQ)
Melbourne, VIC, Australia

Similar investors

Blackbird Ventures
Blackbird is an Australia and New Zealand venture capital firm backing ambitious technology companies from the earliest stages through later growth. It invests across software, deep tech, climate, fintech, health and other technology-led sectors, with portfolio companies including Canva, SafetyCulture, Culture Amp, Zoox and Halter.
Main Sequence
The CSIRO Innovation Fund (managed by and trading as Main Sequence Ventures) is a deeptech fund, investing in companies translating research into global-scale businesses. Main Sequence Ventures knows that this takes more than money. We have our genesis in CSIRO and have access to a deep well of data scientists, physicists, synthetic biologists, chemists, astronomers and experts in other disciples. Each member of the management team has been an entrepreneur and understands the difficulties of building a company. We are here to help. We work harder to understand the world that these founders imagine. We are as comfortable in the lab as we are on the front-line with customers. We will invest capital, and ourselves, to systematically reduce risk and increase opportunity by combining the operational velocity of startups with the deep curiosity of Australia's research sector.
Brandon Capital Partners
Brandon Capital Partners (Brandon Capital) is a life-sciences venture capital firm investing from seed through expansion capital and managing Brandon BioCatalyst, a life-science investment collaboration.
OIF Ventures
We're a leading Australian venture capital firm that champions exceptional founders, driven by purpose, who add material value to their customers, markets, and communities. We invest in early stage companies with innovative, high-growth and disruptive technologies and have deep conviction in the power of technology founders and give our all to make them succeed.
Equity Venture Partners (EVP)
Equity Venture Partners is an early-stage venture capital firm investing in B2B software companies across Australia and New Zealand.
Alium Capital
Alium Capital Management invests in technology and innovation companies across private, secondary and listed markets. Its Innovation Fund targets private companies and generally takes founder-aligned minority stakes as a first institutional investor.

Other Venture Capital Firms in Melbourne

Square Peg Capital
Square Peg is a venture capital firm that invests in emerging technology companies across the internet economy in Australia and New Zealand, Southeast Asia, and Israel.
Uniseed
Uniseed manages Commercialisation and Venture Funds that invest in companies commercialising research from university and research partners, including early-stage deep-tech and life-sciences businesses.
Rampersand
rampersand is an early-stage venture capital firm. We invest in the best Australian technology founders, teams and companies and are committed to helping them become major national, regional and global leaders. The rampersand team has worked with successful startups and technology firms in Australia, Silicon Valley, Israel, Europe and Asia. Our partners have seen numerous companies from the early stages through to successful exits including BEA Systems (acquired by Oracle for US$7.2bn), Jajah (acquired by Telefonica), Snaptu (acquired by Facebook), Onavo (acquired by Facebook), StepStone (acquired by Axel Springer) and Amobee (acquired by Singtel for over US$300m).
Giant Leap Fund
Giant Leap is an impact venture capital investor. It invests in companies harnessing technology and innovation to reimagine industries and create transformational change across climate, health and people, backing mission-driven founders from pre-seed to Series A.
Era VC
Consumer-focused venture capital firm investing in transformative consumer brands across Australia, North America, and Europe; HQ in Melbourne, Australia; invests from seed to growth stages.
Constant Innovation
Constant Innovation is an early-stage venture capital firm based in Australia that invests in high-growth technology businesses.